Last updated: 4 August 2021 at 9:12pm EST

Jonathan Perlin Net Worth




The estimated Net Worth of Jonathan B Perlin is at least $35 Milione dollars as of 2 August 2021. Jonathan Perlin owns over 40,000 units of HCA Healthcare Inc stock worth over $17,235,850 and over the last 14 years he sold HCA stock worth over $11,736,464. In addition, he makes $5,991,260 as President - Clinical Services Group e Chief Medical Officer at HCA Healthcare Inc.

Jonathan Perlin HCA stock SEC Form 4 insiders trading

Jonathan has made over 31 trades of the HCA Healthcare Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 40,000 units of HCA stock worth $10,000,000 on 2 August 2021.

The largest trade he's ever made was exercising 160,000 units of HCA Healthcare Inc stock on 25 July 2018 worth over $3,664,000. On average, Jonathan trades about 22,938 units every 70 days since 2011. As of 2 August 2021 he still owns at least 44,348 units of HCA Healthcare Inc stock.

You can see the complete history of Jonathan Perlin stock trades at the bottom of the page.





Jonathan Perlin biography

Dr. Jonathan B. Perlin M.D. serves as President - Clinical Services Group, Chief Medical Officer of the Company. Dr. Perlin had served as Chief Medical Officer and Senior Vice President — Quality of the Company from August 2006 to November 2007. Prior to joining the Company, Dr. Perlin served as Under Secretary for Health in the U.S. Department of Veterans Affairs since April 2004. Dr. Perlin joined the Veterans Health Administration in November 1999 where he served in various capacities, including as Deputy Under Secretary for Health from July 2002 to April 2004, and as Chief Quality and Performance Officer from November 1999 to September 2002. He also served as Senior Advisor to the Acting Secretary of the U.S. Department of Veterans Affairs from July 2014 to September 2014 and as Chairman for the American Hospital Association in 2015.

What is the salary of Jonathan Perlin?

As the President - Clinical Services Group e Chief Medical Officer of HCA Healthcare Inc, the total compensation of Jonathan Perlin at HCA Healthcare Inc is $5,991,260. There are 5 executives at HCA Healthcare Inc getting paid more, with Samuel Hazen having the highest compensation of $26,788,300.



How old is Jonathan Perlin?

Jonathan Perlin is 58, he's been the President - Clinical Services Group e Chief Medical Officer of HCA Healthcare Inc since 2011. There are 20 older and 15 younger executives at HCA Healthcare Inc. The oldest executive at HCA Healthcare Inc is Dr. Thomas F. Frist Jr., 82, who is the Founder & Chairman Emeritus.

What's Jonathan Perlin's mailing address?

Jonathan's mailing address filed with the SEC is ONE PARK PLAZA, , NASHVILLE, TN, 37203.

Insiders trading at HCA Healthcare Inc

Over the last 14 years, insiders at HCA Healthcare Inc have traded over $32,408,353,888 worth of HCA Healthcare Inc stock and bought 1,077,630 units worth $91,896,364 . The most active insiders traders include Holding Ii, Llc Hercules, Stephen G Pagliuca e Millennium Fund L.P.Kkr Ass.... On average, HCA Healthcare Inc executives and independent directors trade stock every 9 days with the average trade being worth of $570,965,326. The most recent stock trade was executed by Timothy M Mc Manus on 31 July 2024, trading 7,500 units of HCA stock currently worth $578,475.



What does HCA Healthcare Inc do?

HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968.



Complete history of Jonathan Perlin stock trades at HCA Healthcare Inc

Persona
Trans.
Transazione
Prezzo totale
Jonathan B Perlin
Pres-Clinical Operations e CMO
Vendita $10,000,000
2 Aug 2021
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $9,952,268
23 Apr 2021
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $3,327,919
3 Feb 2021
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $1,663,805
13 Nov 2020
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $1,394,250
9 Nov 2020
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $464,750
5 Nov 2020
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $464,750
7 Nov 2018
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $3,664,000
25 Jul 2018
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $266,875
21 Jun 2018
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $433,250
11 Jun 2018
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $199,642
17 May 2018
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $666,858
16 Feb 2018
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $420,502
31 Jan 2018
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $961,239
11 Aug 2017
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $658,043
22 Jun 2017
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $381,798
1 Feb 2017
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $173,400
27 Apr 2016
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $362,353
25 Jun 2015
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $407,520
18 May 2015
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $113,200
23 Dec 2014
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $113,200
3 Nov 2014
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $226,400
29 Oct 2014
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $115,600
1 Aug 2014
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $115,600
3 Jun 2014
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $57,800
30 Apr 2014
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $98,904
13 Feb 2014
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $95,591
25 Nov 2013
Jonathan B Perlin
Pres-Clinical Operations e CMO
Vendita $1,736,464
25 Feb 2013
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $318,632
14 Feb 2013
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $159,316
2 Nov 2011
Jonathan B Perlin
Pres-Clinical Operations e CMO
Opzione $187,857
15 Mar 2011


HCA Healthcare Inc executives and stock owners

HCA Healthcare Inc executives and other stock owners filed with the SEC include: